ARCHIVES

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

November 14, 1975

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001